David Charles Link - 16 Dec 2025 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ David Charles Link
Issuer symbol
SABS
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
18 Dec 2025, 16:40:03 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Link David Director 777 W 41ST STREET, SUITE 401, MIAMI BEACH /s/ David Charles Link 18 Dec 2025 0002085171

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 16 Dec 2025 Common Stock 150,000 $3.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027.
F2 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.